![]() | Up a level |
(2023) CRISPR/Cas9, a promising approach for the treatment of beta-thalassemia: a systematic review. Molecular Genetics and Genomics. pp. 1-11. ISSN 1617-4615
(2023) CRISPR/Cas9, a promising approach for the treatment of β-thalassemia: a systematic review. Molecular Genetics and Genomics. pp. 1-11. ISSN 16174615 (ISSN)
(2020) How to Assess Founder Effect in Patients with Congenital Factor XIII Deficiency. International journal of hematology-oncology and stem cell research. pp. 265-273. ISSN 2008-3009 (Print) 2008-2207 (Linking)